PE20060123A1 - DERIVADOS DE FENILETANOLAMINA COMO AGONISTAS DE ß-2 - Google Patents

DERIVADOS DE FENILETANOLAMINA COMO AGONISTAS DE ß-2

Info

Publication number
PE20060123A1
PE20060123A1 PE2005000297A PE2005000297A PE20060123A1 PE 20060123 A1 PE20060123 A1 PE 20060123A1 PE 2005000297 A PE2005000297 A PE 2005000297A PE 2005000297 A PE2005000297 A PE 2005000297A PE 20060123 A1 PE20060123 A1 PE 20060123A1
Authority
PE
Peru
Prior art keywords
phenyl
hydroxy
alkyl
phenylethanolamine
agonists
Prior art date
Application number
PE2005000297A
Other languages
English (en)
Inventor
Alan Daniel Brown
Mark Edward Bunnage
Charlotte Alice Louise Lane
Graham Lunn
David Anthony Price
Russell Andrew Lewthwaite
Paul Alan Glossop
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04290725A external-priority patent/EP1577291A1/en
Priority claimed from GB0425064A external-priority patent/GB0425064D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of PE20060123A1 publication Critical patent/PE20060123A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE REIERE A DERIVADOS DE FENILETANOLAMINA DE FORMULA (I), EN DONDE EL GRUPO (CH2)n-C(=O)Q1 ESTA EN POSICION RELATIVA META O PARA; R1 Y R2 SON INDEPENDIENTEMENTE H O ALQUILO(C1-C4); n ES DE 0 A 2; Q1 ES UN GRUPO a), b), c), -NH-ALQUILO(C1-C4) O -N(R8)-Q2-A, EN DONDE Q2 ES UN ENLACE SENCILLO O ALQUILENO(C1-C4); R8 ES H O ALQUILO(C1-C4); p ES 1 O 2; A ES CICLOALQUILO (C3-C10), O-FENILPIRAZOLILO, UN HETEROCICLICO DE 5 A 10 MIEMBROS, O NAFTALENIL O FENIL, OPCIONALMENTE SUSTITUIDOS. SON COMPUESTOS PREFERIDOS: N-CICLOHEPTIL-2-{3-[(2R)-2-({(2R)-2-HIDROXI-2-[4-HIDROXI-3-(HIDROXIMETIL)FENIL]ETIL}AMINO)PROPIL}FENIL]-ACETAMIDA, N-(3,4-DICLOROBENCIL)-3-{3-[2-({(2R)-2-HIDROXI-2-[4-HIDROXI-3-(HIDROXIMETIL)FENIL]ETIL}AMINO)-2-METILPROPIL]-FENIL}PROPANAMIDA, ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA. ESTOS COMPUESTOS SON AGONISTAS DE RECEPTORES ADRENERGICOS ß2, POR LO QUE SON UTILES PARA EL TRATAMIENTO DE ENFERMEDADES Y TRANSTORNOS INFLAMATORIOS, ALERGICOS Y RESPIRATORIOS
PE2005000297A 2004-03-17 2005-03-15 DERIVADOS DE FENILETANOLAMINA COMO AGONISTAS DE ß-2 PE20060123A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04290725A EP1577291A1 (en) 2004-03-17 2004-03-17 Phenylethanolamine derivatives as beta-2 agonists
US59179004P 2004-07-27 2004-07-27
GB0425064A GB0425064D0 (en) 2004-11-12 2004-11-12 Compounds useful for the treatment of diseases

Publications (1)

Publication Number Publication Date
PE20060123A1 true PE20060123A1 (es) 2006-03-08

Family

ID=34961252

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2005000297A PE20060123A1 (es) 2004-03-17 2005-03-15 DERIVADOS DE FENILETANOLAMINA COMO AGONISTAS DE ß-2

Country Status (13)

Country Link
KR (1) KR20070026420A (es)
AP (1) AP2006003743A0 (es)
AR (1) AR048267A1 (es)
EC (1) ECSP066854A (es)
IL (1) IL177754A0 (es)
MA (1) MA28475B1 (es)
NL (1) NL1028559C2 (es)
NO (1) NO20063875L (es)
PA (1) PA8626401A1 (es)
PE (1) PE20060123A1 (es)
SV (1) SV2005002052A (es)
TW (1) TWI281396B (es)
UY (1) UY28810A1 (es)

Also Published As

Publication number Publication date
IL177754A0 (en) 2006-12-31
MA28475B1 (fr) 2007-03-01
ECSP066854A (es) 2006-11-24
SV2005002052A (es) 2005-12-13
AP2006003743A0 (en) 2006-10-31
TWI281396B (en) 2007-05-21
TW200534846A (en) 2005-11-01
PA8626401A1 (es) 2006-05-16
NL1028559A1 (nl) 2005-09-20
KR20070026420A (ko) 2007-03-08
UY28810A1 (es) 2005-10-31
NL1028559C2 (nl) 2006-04-19
AR048267A1 (es) 2006-04-12
NO20063875L (no) 2006-09-26

Similar Documents

Publication Publication Date Title
PE20050628A1 (es) DERIVADOS DE 2-AMINO-PIRIDINA COMO AGONISTAS ß-2
PE20040775A1 (es) DERIVADOS DE INDOL COMO AGONISTAS DE ADRENORECEPTORES ß2
PE20050765A1 (es) DERIVADOS DE SULFONAMIDA COMO AGONISTAS DE LOS RECEPTORES ß2 ADRENERGICOS
PE20061150A1 (es) Derivados de n-(n-sulfonilaminoarilmetil)ciclopropanocarboxamida sustituidos como antagonistas del receptor vainilloide tipo 1 (vdr1)
PE20061163A1 (es) Compuestos de n-sulfonilaminofeniletil-2-fenoxiacetamida sustituidos
PE20051136A1 (es) Derivados de sulfonamida
ATE420859T1 (de) Azabicycloä3.1.0ühexylphenylderivate als modulatoren von dopamin-d3-rezeptoren
PE20091201A1 (es) AMIDAS SUSTITUIDAS COMO INHIBIDORES DE LA TIROSINA QUINASA DE BRUTON (Btk)
PE20241727A1 (es) Inhibidores de nlrp3
AR071530A1 (es) Derivados de tienopiridonas como activadores de proteina quinasa activa-dos por amp (ampk)
PE20170705A1 (es) Nuevos compuestos como inhibidores de ret (reorganizado durante la transfeccion)
PE20120345A1 (es) Derivados de 2-(1h-pirrolo[2,3-b]piridin-5-iloxi)-n-fenilsulfonilbenzamida como inhibidores de proteinas anti-apoptoticas
PE20110285A1 (es) Derivados de sulfonamidofenil propionamida como ligandos del receptor vaniloide del subtipo 1
CY1108908T1 (el) Ενωσεις κινολινονης - καρβοξαμιδης ως αγωνιστες υποδοχεων 5-ητ4
PE20090547A1 (es) DERIVADOS DE PIRAZINONA COMO INHIBIDORES DE p38 QUINASA
RU2008108898A (ru) Соединения и композиции в качестве ингибиторов протеинкиназы
PE20211388A1 (es) Compuestos
RU2015105561A (ru) Замещенные гетероазепиноны
PE20071112A1 (es) Derivados azufrados de urea ciclica como inhibidores de quinasas y su preparacion
PE20120508A1 (es) Inhibidores de la replicacion de los virus de la gripe
PE20070113A1 (es) Derivados de quinolina y quinazolina como inhibidores de tirosinquinasas flt3 y trkb
PE20080061A1 (es) Compuestos derivados de amida como inhibidores de los canales de potasio task-1 y task-3
PE20210176A1 (es) Inhibidores de arginasa y sus metodos de uso
PE20191108A1 (es) Inhibidores selectivos de jak1
PE20091092A1 (es) Compuestos heterociclicos como inhibidores de la via hedgehog

Legal Events

Date Code Title Description
FD Application declared void or lapsed